regulatory – Pharma GMP

Regulatory Expectations for Bulk Product Hold Time Justification

digi — Wed, 26 Nov 2025 04:06:04 +0000

Regulatory Expectations for Bulk Product Hold Time Justification Comprehensive Guide to Bulk Product Hold Time Justification: Regulatory Expectations and Approval Hold time studies for bulk product represent a critical component in pharmaceutical manufacturing, impacting product quality, regulatory compliance, and operational efficiency. This step-by-step tutorial provides pharmaceutical manufacturing, QA, QC, validation, and regulatory affairs professionals in...

Change Control Impact Assessment: Product, Validation and Regulatory

digi — Tue, 25 Nov 2025 19:48:04 +0000

Change Control Impact Assessment: Product, Validation and Regulatory Step-by-Step Guide to Change Control Impact Assessment in Pharma: Product, Validation, and Regulatory Considerations Change control is a fundamental component of a compliant and effective Quality Management System (QMS) in pharmaceutical manufacturing. Properly assessing the impact of a change in a pharmaceutical setting ensures not only continued...

Case Studies: Stability QC Failures and Regulatory Impact

digi — Tue, 25 Nov 2025 10:51:04 +0000

Case Studies: Stability QC Failures and Regulatory Impact Understanding the Role of QC Laboratory in Stability Testing: Case Studies on Failures and Regulatory Consequences The stability of pharmaceutical products over their shelf life critically affects their safety and efficacy. The role of QC laboratory in stability testing is pivotal to ensuring that drug products meet...

Regulatory Expectations for Bulk Product Hold Time Justification

digi — Mon, 24 Nov 2025 22:54:42 +0000

Regulatory Expectations for Bulk Product Hold Time Justification Step-by-Step Guide to Regulatory Expectations for Bulk Product Hold Time Justification Within pharmaceutical manufacturing, the justification and control of bulk product hold times constitute a critical element of Good Manufacturing Practice (GMP). Regulatory authorities across the US, UK, and EU impose stringent requirements to ensure the integrity,...

How to Present Your Process Control Strategy in Regulatory Inspections

digi — Mon, 24 Nov 2025 22:42:42 +0000

How to Present Your Process Control Strategy in Regulatory Inspections Step-by-Step Guide: How to Present Your Process Control Strategy During Regulatory Inspections Pharmaceutical manufacturing organizations operate under stringent regulations to guarantee product quality, safety, and efficacy. One critical aspect of complying with these regulations involves establishing and maintaining a robust process control strategy. Regulatory inspections...

IPC Checklist for Tablet Compression: Weight

digi — Mon, 24 Nov 2025 18:54:42 +0000

IPC Checklist for Tablet Compression: Weight In-Process Control Checklist for Tablet Compression: Weight and Related Parameters In the pharmaceutical manufacturing environment, ensuring rigorous In-Process Controls (IPC) during tablet compression is fundamental to maintaining product quality and compliance with regulatory expectations. IPC checkpoints such as tablet weight, hardness, and friability checks form the backbone of effective...

IPC Checklist for Tablet Compression: Weight

digi — Mon, 24 Nov 2025 18:54:42 +0000

IPC Checklist for Tablet Compression: Weight Control and Hardness Testing Step-by-step IPC Checklist for Tablet Compression: Weight Control, Hardness, and Friability In pharmaceutical tablet manufacturing, In-Process Control (IPC) is pivotal to ensure product quality, uniformity, and adherence to regulatory standards throughout the tablet compression stage. This tutorial provides a comprehensive, stepwise IPC checklist focusing on...

GMP Biologics Manufacturing: Control Strategies for Biosimilars and Novel Biologics

digi — Fri, 14 Nov 2025 19:56:47 +0000

GMP Biologics Manufacturing: Control Strategies for Biosimilars and Novel Biologics Control Strategies in GMP Biologics Manufacturing for Biosimilars and Innovative Biologics The manufacturing of biologics, including biosimilars and novel biologic entities, demands sophisticated control strategies within the framework of gmp biologics manufacturing. These controls are essential to ensure product quality, safety, and efficacy throughout the...